BeStock  
Stocks › ABUS

Arbutus Biopharma ABUS

US equityMarket cap rank #3392
$4.08 −$0.21 (-4.96%)
Market open · Oct 8, 11:40 am ET · After hours $4.30 +0.23%
Open$4.22
Prev close$4.29
Day range$4.05 – $4.30
Volume1.62M
Market cap$807.76M
P/E (TTM)5.2
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings5.4x
CheapRich

Near the top of its 5-year range · 95th percentile, 5-year average -6.8x

#210 of 2973 stocks by PE (1 = cheapest)

Price / book3.3x
CheapRich

Around its usual level · 43rd percentile, 5-year average 3.6x

#3795 of 5317 stocks by PB (1 = cheapest)

Price / sales4.7x
CheapRich

Near the bottom of its 5-year range · 3rd percentile, 5-year average 41.2x

#3785 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-30x-17x-4x9xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$3.69
Price vs. fair value+10.4%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.28 – 3.58 43% (cheaper than usual) #3795 of 5317 (1 = cheapest)
PE 5.43 -52.00 -6.82 95% (pricier than usual) #210 of 2973 (1 = cheapest)
PS 4.68 218.34 41.20 3% (cheaper than usual) #3785 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$3.69
Economic moatNone
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on ABUS.

Leave a comment

Scroll to Top